Please use this identifier to cite or link to this item:
|Title:||Association of the POT1 germline missense variant pI78T with familial melanoma|
Robles Espinoza, Daniela
Rudat, Saskia S.
Puig i Sardà, Susana
Potrony Mateu, Míriam
Wong, Chi C.
Puig Butillé, Joan Anton
Bressac-de Paillerets, Brigitte
van der Weyden, Louise
Fletcher, Christopher D. M.
Arends, Mark J.
Newton-Bishop, Julia A.
López Otin, Carlos
Bishop, D. Timothy
Harms, Paul W.
Johnson, Timothy M.
Durham, Alison B.
Lombard, David B.
|Keywords:||Càncer de pell|
|Publisher:||American Medical Association|
|Abstract:||IMPORTANCE: The protection of telomeres 1 protein (POT1) is a critical component of the shelterin complex, a multiple-protein machine that regulates telomere length and protects telomere ends. Germline variants in POT1 have been linked to familial melanoma, and somatic mutations are associated with a range of cancers including cutaneous T-cell lymphoma (CTCL). OBJECTIVE: To characterize pathogenic variation in POT1 in families with melanoma to inform clinical management. DESIGN, SETTING, AND PARTICIPANTS: In this case study and pedigree evaluation, analysis of the pedigree of 1 patient with melanoma revealed a novel germline POT1 variant (p.I78T, c.233T>C, chromosome 7, g.124870933A>G, GRCh38) that was subsequently found in 2 other pedigrees obtained from the GenoMEL Consortium. MAIN OUTCOMES AND MEASURES: (1) Identification of the POT1 p.I78T variant; (2) evaluation of the clinical features and characteristics of patients with this variant; (3) analysis of 3 pedigrees; (4) genomewide single-nucleotide polymorphism genotyping of germline DNA; and (5) a somatic genetic analysis of available nevi and 1 melanoma lesion. RESULTS: The POT1 p.I78T variant was found in 3 melanoma pedigrees, all of persons who self-reported as being of Jewish descent, and was shown to disrupt POT1-telomere binding. A UV mutation signature was associated with nevus and melanoma formation in POT1 variant carriers, and somatic mutations in driver genes such as BRAF, NRAS, and KIT were associated with lesion development in these patients. CONCLUSIONS AND RELEVANCE: POT1 p.I78T is a newly identified, likely pathogenic, variant meriting screening for in families with melanoma after more common predisposition genes such as CDKN2A have been excluded. It could also be included as part of gene panel testing.|
|Note:||Reproducció del document publicat a: https://doi.org/10.1001/jamadermatol.2018.3662|
|It is part of:||JAMA Dermatology, 2018, vol. 155, num. 5, p. 604-609|
|Appears in Collections:||Articles publicats en revistes (Medicina)|
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Files in This Item:
|688551.pdf||632.79 kB||Adobe PDF||View/Open|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.